Calib-og, Baby Girl .
HRN: 21-26-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/25/2022
07/02/2022
IV
37mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes